The most expensive pharmaceuticals include Zolgensma, Zokinvy, Danyelza, Luxturna, Ravicti, Myalept, and more.

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the ...

Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...